At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 26 enrolled
Drug / intervention
hydrocortisone 17-butyrate 0.1% Cream preparation +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
In Brief
A Phase 4 clinical trial evaluating hydrocortisone 17-butyrate 0.1% Cream preparation, hydrocortisone 17-butyrate 0.1% Ointment preparation, and 1 other intervention for Atopic Dermatitis. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2006
First PostedJun 2008
Primary CompletionSep 2008
TodayJul 2026
First PostedJun 9, 2008
Enrollment StartNov 1, 2006
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 18.1 years ago
Interventions
hydrocortisone 17-butyrate 0.1% Cream preparationdrug
Apply medication twice a day to affected areas of atopic dermatitis
hydrocortisone 17-butyrate 0.1% Ointment preparationdrug
Apply medication twice a day to affected areas of atopic dermatitis
hydrocortisone 17-butyrate 0.1% Lipocream preparationdrug
Apply medication twice a day to affected areas of atopic dermatitis